Assessing the Future of Robotics in Medtech

Posted by Andy Kach on August 14, 2019

This article was originally published in Medtech Insight.

Every medical device company—in and out of the surgical business—and many other tech companies are deep in the war of surgical robotics and digital solutions.


>
Read More

Medtech’s Business Problems Need Marketing Solutions

Posted by Matt Singer on June 5, 2019

Sundeep Karnik co-wrote this blog post with Matt Singer. This is an excerpt from “Medtech, Look to Marketing for the Solution.”

We don’t need to tell you that the healthcare landscape is growing more complex and competitive, and that achieving growth is becoming more challenging for medtech organizations. We don’t need to mention that bringing true innovation to market—innovation that customers will pay for—isn’t as easy as it used to be or that many new product launches fail to deliver on expectations. We’ve sat in the offices of many industry leaders and discussed these very challenges.


>
Read More

Are You Starving Your Innovation?

Posted by Roz Lawson on October 26, 2016

 

A recent review of global medtech business reports that the sector’s total revenue fell in the past year for the first time since 2011, U.S. and European medtech financing dropped, and top management of established medtech companies appears to be focusing on short-term allocation of capital, turning $13 billion over to shareholders in 2015 rather than reinvesting it in their companies. Both large and small companies are limiting their investment in taking new technologies to market and expanding their customer base.

The risk-averse climate isn’t surprising. Historically, many companies have struggled to recognise the benefits of an acquisition due to a focus on short-term results. Take the example of a big company that has acquired a promising device from an innovative startup, integrated it into their less-than-agile decision-making structure, and then managed it with a one-year-return mentality to satisfy their shareholders. The result? Unsurprisingly, growth falters, and then investment is restricted, so growth stalls, and so on. A few years down the line, the big company is considering selling off its once-promising asset. I won’t name names, but I can think of many examples, and some big companies are serial offenders.


>
Read More

Four Barriers to Innovation in Diabetes Blood Glucose Monitoring

Posted by Andy Kach on July 22, 2016


Diabetes is currently one of the fastest-growing diseases facing our generation. In the U.S., diabetes’ prevalence is growing at an alarming rate, having doubled from around 11 million American cases in 2000 to around 22 million in 2014, according to the CDC. Because of the size of the market for diabetes medical devices and the high growth rate of the disease, there are a lot of eyes watching what’s happening and looking for ways to invest. Since diabetes is currently incurable, it’s a very expensive disease, particularly when it starts early in a person’s lifetime. Many medical device organizations, technology companies and entrepreneurs are looking to get their foot in the door.


>
Read More

Medtech Firms Must Innovate With Hospital Economics in Mind

Posted by Brian Chapman on May 21, 2015

ZS surveyed members of the Healthcare Leadership Council and presented findings at the National Dialogue for Healthcare Innovation summit in Washington, DC. My colleague Bill Coyle led the effort, which studied healthcare executives to highlight the issues facing our industry.


>
Read More